Merck & Co.

1
Public Policy Statement | January 2024
Expanding Access to
Merck’s Investigational
Medicines

When results from clinical trials suggest that one of our investigational medicines may
offer benefits for patients facing life-threatening conditions, Merck is committed to
bringing that medicine to those patients as quickly and equitably as possible. Participation
in clinical trials should be the primary route by which patients get access to investigational
medicines and contribute to the...